Results 261 to 270 of about 45,720 (293)
Some of the next articles are maybe not open access.
Mental Retardation and Developmental Disabilities Research Reviews, 1999
The nature of anxiety and its biological basis is reviewed, as are the causes and types of pathological anxiety and their pharmacological treatment. The main drugs used in the treatment of anxiety work by depressing the brain and hence perception and response to stressors.
openaire +2 more sources
The nature of anxiety and its biological basis is reviewed, as are the causes and types of pathological anxiety and their pharmacological treatment. The main drugs used in the treatment of anxiety work by depressing the brain and hence perception and response to stressors.
openaire +2 more sources
2006
Publisher Summary Drugs used for relieving anxiety, stress, worry, and fear that do not detract attention from or affect psychomotor activity of the patient are called anxiolytics or tranquilizers. Most of them have sedative and hypnotic action, and in high doses their effects are in many ways similar to barbiturate action.
Ruben Vardanyan, Victor J. Hruby
openaire +3 more sources
Publisher Summary Drugs used for relieving anxiety, stress, worry, and fear that do not detract attention from or affect psychomotor activity of the patient are called anxiolytics or tranquilizers. Most of them have sedative and hypnotic action, and in high doses their effects are in many ways similar to barbiturate action.
Ruben Vardanyan, Victor J. Hruby
openaire +3 more sources
Pharmacology Biochemistry and Behavior
Anxiety disorders are the most prevalent psychiatric pathology with substantial cost to society, but the existing treatments are often inadequate. This has rekindled the interest in the GABAA-receptor (GABAAR) positive allosteric modulator (PAM) compounds, which have a long history in treatment of anxiety beginning with diazepam, chlordiazepoxide, and ...
Rok, Cerne+3 more
openaire +2 more sources
Anxiety disorders are the most prevalent psychiatric pathology with substantial cost to society, but the existing treatments are often inadequate. This has rekindled the interest in the GABAA-receptor (GABAAR) positive allosteric modulator (PAM) compounds, which have a long history in treatment of anxiety beginning with diazepam, chlordiazepoxide, and ...
Rok, Cerne+3 more
openaire +2 more sources
2016
This chapter will present clinical evidence for the efficacy of herbal treatments which address symptoms of anxiety primarily via their effects on cognitive functioning. Brahmi (Bacopa monnieri) Ginkgo (Ginkgo Biloba) Lemon Balm (Melissa officinalis) Tea (Camellia sinensis) Sage (Salvia spp.) Rosemary (Rosmarinus officinalis)
Steiner, Genevieve Z. (R18023)+1 more
openaire +1 more source
This chapter will present clinical evidence for the efficacy of herbal treatments which address symptoms of anxiety primarily via their effects on cognitive functioning. Brahmi (Bacopa monnieri) Ginkgo (Ginkgo Biloba) Lemon Balm (Melissa officinalis) Tea (Camellia sinensis) Sage (Salvia spp.) Rosemary (Rosmarinus officinalis)
Steiner, Genevieve Z. (R18023)+1 more
openaire +1 more source
Anxiolytics, sedatives and hypnotics
Anaesthesia & Intensive Care Medicine, 2007Anxiolytics and sedatives are used in current anaesthetic practice for anxiolysis before surgery and as adjuvants during anaesthesia. The safety profile of these agents depends on their pharmacokinetic and pharmacodynamic profiles, patient comorbidity and the experience of the clinician.
Anthony Absalom, Caroline Meerts
openaire +3 more sources
Anxiolytic effects of benzalphthalides
Bioorganic & Medicinal Chemistry Letters, 2005Anxiolytic effects induced by benzalphthalides on mice have been evaluated. The evaluation was based on the spent time and the number of entries of animals into the open arms in the elevated plus maze test. Single administration of benzalphthalides 1 and 11 induced significant increments in both parameters, thus revealing their potentiality as new ...
Maribel Herrera-Ruiz+5 more
openaire +3 more sources
Anaesthesia & Intensive Care Medicine, 2004
Abstract Drugs such as the barbiturates and the benzodiazepine have anxiolytic and hypnotic activity and both act by enhancing the action of γ-aminobutyric acid (GABA) via an action at separate binding sites of the GABA A receptor. While anxiolytic activity was not a particular disadvantage when these drugs were used as hypnotics, hypnosis was a ...
openaire +2 more sources
Abstract Drugs such as the barbiturates and the benzodiazepine have anxiolytic and hypnotic activity and both act by enhancing the action of γ-aminobutyric acid (GABA) via an action at separate binding sites of the GABA A receptor. While anxiolytic activity was not a particular disadvantage when these drugs were used as hypnotics, hypnosis was a ...
openaire +2 more sources
Neuropharmacology of Sedatives and Anxiolytics
2015Sedative drugs are intended to cause various degrees of drowsiness. Animal experiments indicate that barbiturates induce these effects primarily by depression of the reticular activating system in the rostral brainstem. This in turn potentiates the thalamic recruiting system, thereby inducing 'barbiturate bursts' in the EEG.
William Schallek, Walter Schlosser
openaire +3 more sources
Behavioral effects of several new anxiolytics and putative anxiolytics
European Journal of Pharmacology, 1987The behavioral effects of several new anxiolytics and putative anxiolytics were evaluated in two tests sensitive for anxiolytic activity. In the first test, rats were trained to lever-respond for sweetened milk under a multiple variable-interval fixed-ratio (VI-FR) schedule of reinforcement. In the FR component a brief electric shock coincided with the
Tracey A. Emrey+4 more
openaire +3 more sources
Interaction of GABA and serotonin in the anxiolytic action of diazepam and serotonergic anxiolytics
Pharmacology Biochemistry and Behavior, 1992The general purpose of the present study was to analyze the possible interactions between the GABA-benzodiazepine and the serotonergic (5-HT) systems in the anxiolytic action of diazepam and the 5-HT1A agonists, ipsapirone, indorenate, and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
Carolina López-Rubalcava+2 more
openaire +3 more sources